| http://www.w3.org/ns/prov#value | - We are pleased that the core value of Potelligent Technology has been recognized by a global pharmaceutical company such as Pfizer, and are excited to work together with Pfizer on their innovative antibody research pipelines, said Dr Yasunori Yamaguchi, president and CEO of BioWa.
|